Publication | Open Access
Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised study
124
Citations
22
References
2017
Year
Wellcome Trust, UK Department for International Development, Global Health Innovative Technology Fund, Bill & Melinda Gates Foundation.
| Year | Citations | |
|---|---|---|
Page 1
Page 1